跳至主要内容
临床试验/NL-OMON40001
NL-OMON40001已完成不适用

Aberrant receptor expression in thyroid tissue: A role in the pathogenesis of multinodular goiter? A pilot study - Aberrant receptor expression in thyroid tissue

Academisch Medisch Centrum0 个研究点目标入组 15 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Informed consent form signed
  • * Age 18 years and over
  • * Multinodular goiter, confirmed with thyroid ultrasound
  • * Subclinical hyperthyroidism, defined as TSH < 0.10 mE/l and free T4 within reference range [10.0 * 23.0 pmol/l]
  • * T3 level within reference range, i.e. between 1.30 and 2.70 nmol/l

排除标准

  • * Current use of antithyroid drugs
  • * Treatment with radioactive iodine in history
  • * Pregnancy. This condition may lead to subtle enlargement of the thyroid gland, secondary to iodine deficiency. All premenopausal female participants will undergo a *-hCG-urine test before inclusion.
  • * Born and raised in iodine deficient areas, defined as the green and dark green fields in Figure 3 (protocol, p 13) .
  • * Any medication known to interfere with thyroid hormone metabolism or with the study medication, like amiodarone, beta blockers, neuroleptics, corticosteroids including inhalation steroids, antihistaminics
  • * Any condition that the investigator feels would interfere with trial participation or evaluation of results

研究者

相似试验